China: 2011 Adverse Reaction Report Released

Posted 01 June 2012 | By Louise ZornozaRegLink

China's State Food and Drug Administration (SFDA) has released a report detailing the adverse event reports it received during 2011. The report notes events involving anti-infective medicines accounted for the higher number of reports, including cephalosporins (34.8%), penicillin (14%) and quinolones (12.2%).

New and serious adverse drug reactions accounted for 17.1% of the total number of reports.  Medical institutions were the primary source for such reports, accounting for about 83% of all reported events.


Read more:

2011 adverse reactions report

More Breaking News from RegLink


Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe